[ad_1]
At the botulinum toxin strain workshop that has been running for more than five years, the US International Trade Commission (ITC) gave hands to Medytox, and domestic stock prices showed opposite trends.
Prior to that, on the 17th, the ITC supported an administrative judge’s ruling that Daewoong Pharmaceutical and its partner, Ebolus, infringed on Medytox trade secrets, and decided that Nabota (US product name bulletin) would not be allowed to Import into the United States for 21 months.
The decision will be made after receiving the final decision from the President of the United States within 60 days, but there are many evaluations that it will be unfavorable for Daewoong Pharmaceutical as there are not many precedents to overturn the ITC decision.
However, contrary to the ruling of the administrative judge, the Committee decided that the strain was not a trade secret and the import ban was drastically reduced from 10 years to 21 months, which is quite favorable for Daewoong Pharmaceutical.
On the 17th, on the national stock exchange, Daewoong Pharmaceutical, which added news of the clinical progress of the COVID-19 treatment candidate, registered an upper limit, while both companies claimed to be their own victory, while Medytox fell more than 5 %, showing opposite trends.
According to the Korean Stock Exchange, on the 17th, the pharmaceutical index in the stock market rose 36.63p (+ 0.18%) compared to the previous day to 22,580.53, and the pharmaceutical index in the KOSDAQ market fell 52.13p (-0.38%) from the previous day to 13,815.98.
By shares, Daewoong Pharmaceutical posted an upper bound between the components of the pharmaceutical index, while Chong Kun Dang shares (+ 5.16%) rose more than 5%.
In the pharmaceutical index components, Medipost (+ 13.99%) posted a double-digit growth rate, and Humasys’s growth rate (+ 8.43%) also exceeded 5%.
On the other hand, the components of the pharmaceutical index include Pamicel (-8.27%), components of the pharmaceutical index such as Naivec (-6.67%), NKmax (-6.63%), Medytox (-5.60%) and Oscotek (-5.12%). The share price fell more than 5%.
Copyright © Medical News Unauthorized reproduction and redistribution prohibited
